dc.contributor.author | Taslimi, Parham | |
dc.contributor.author | Gulcin, Ilhami | |
dc.contributor.author | Ozgeris, Bunyamin | |
dc.contributor.author | Goksu, Suleyman | |
dc.contributor.author | Tumer, Ferhan | |
dc.contributor.author | Alwasel, Saleh H. | |
dc.contributor.author | Supuran, Claudiu T. | |
dc.date.accessioned | 2019-06-13T06:55:21Z | |
dc.date.available | 2019-06-13T06:55:21Z | |
dc.date.issued | 2016-01 | |
dc.identifier.uri | http://hdl.handle.net/11772/1390 | |
dc.description.abstract | Carbonic anhydrases (CAs, EC 4.2.1.1) had six genetically distinct families described to date in various organisms. There are 16 known CA isoforms in humans. Human CA isoenzymes I and II (hCA I and hCA II) are ubiquitous cytosolic isoforms. Acetylcholine esterase (AChE. EC 3.1.1.7) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine relaying the signal from the nerve. In this study, some trimethoxyindane derivatives were investigated as inhibitors against the cytosolic hCA I and II isoenzymes, and AChE enzyme. Both hCA isozymes were inhibited by trimethoxyindane derivatives in the low nanomolar range. These compounds were good hCA I inhibitors (Kis in the range of 1.66-4.14nM) and hCA II inhibitors (Kis of 1.37-3.12nM) and perfect AChE inhibitors (Kis in the range of 1.87-7.53nM) compared to acetazolamide as CA inhibitor (Ki: 6.76nM for hCA I and Ki: 5.85nM for hCA II) and Tacrine as AChE inhibitor (Ki: 7.64nM). | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Informa | en_US |
dc.relation.isversionof | 10.3109/14756366.2015.1014476 | en_US |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_US |
dc.subject | Acetylcholine esterase | en_US |
dc.subject | Enzyme inhibition | en_US |
dc.subject | Enzyme purification | en_US |
dc.subject | Trimethoxyindane derivatives | en_US |
dc.subject | Affinity chromatography | en_US |
dc.subject | Carbonic anhydrase | en_US |
dc.title | The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives | en_US |
dc.type | article | en_US |
dc.relation.journal | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
dc.contributor.department | Bartın Üniversitesi, Fen Fakültesi, Biyoteknoloji Bölümü | en_US |
dc.identifier.volume | 31 | en_US |
dc.identifier.startpage | 152 | en_US |
dc.identifier.endpage | 157 | en_US |